HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 11.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,072,266 shares of the company’s stock after selling 143,055 shares during the period. JPMorgan Chase & Co.’s holdings in HealthEquity were worth $102,884,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wealthfront Advisers LLC purchased a new stake in HealthEquity during the 4th quarter valued at approximately $10,304,089,000. Raymond James Financial Inc. purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $45,728,000. Artisan Partners Limited Partnership acquired a new stake in shares of HealthEquity during the fourth quarter worth $24,568,000. Geneva Capital Management LLC grew its position in HealthEquity by 24.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock valued at $100,642,000 after buying an additional 206,894 shares during the last quarter. Finally, Barclays PLC increased its stake in HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after buying an additional 112,667 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $88.74 on Thursday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The stock has a market cap of $7.68 billion, a P/E ratio of 81.41, a PEG ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average of $102.66 and a two-hundred day moving average of $96.30.

Analyst Upgrades and Downgrades

HQY has been the topic of several analyst reports. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. KeyCorp cut their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. The Goldman Sachs Group decreased their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Finally, Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and an average price target of $112.58.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.